The first Atricure trade was made in Q2 2021.
Since then Ray Dalio bought shares six more times and sold shares on eight occasions. The investor completely sold their stake between Q2 2024 and Q4 2024.
Avg closing price
Price range
Sold -19.7 Thousand shares
Q4 2024
Avg closing price
$32.18
Price range
$27.02
-
$38.20
Sold 51.2% shares (-20.6 Thousand shares)
Q3 2024
Avg closing price
$24.64
Price range
$20.34
-
$29.50
Sold 12.4% shares (-5.69 Thousand shares)
Q2 2024
Avg closing price
$23.08
Price range
$19.86
-
$29.09
Increased shares by 125.2% (+25.6 Thousand shares)
Q1 2024
Avg closing price
$33.50
Price range
$28.21
-
$37.78
Sold 6.9% shares (-1.52 Thousand shares)
Q4 2023
Avg closing price
$37.19
Price range
$32.99
-
$43.25
Sold 63.8% shares (-38.7 Thousand shares)
Q3 2023
Avg closing price
$48.78
Price range
$41.12
-
$57.73
Sold 7.2% shares (-4.68 Thousand shares)
Q2 2023
Avg closing price
$46.09
Price range
$40.44
-
$49.60
Increased shares by 21.9% (+11.7 Thousand shares)
Q1 2023
Avg closing price
$41.50
Price range
$35.87
-
$47.22
Sold 25.4% shares (-18.2 Thousand shares)
Q4 2022
Avg closing price
$41.77
Price range
$33.48
-
$47.45
Increased shares by 0.1% (+93 shares)
Q3 2022
Avg closing price
$45.75
Price range
$38.25
-
$52.62
Increased shares by 10.8% (+6.98 Thousand shares)
Q2 2022
Avg closing price
$47.37
Price range
$35.10
-
$66.01
Increased shares by 32.6% (+15.9 Thousand shares)
Q1 2022
Avg closing price
$64.80
Price range
$57.43
-
$71.39
Increased shares by 16.5% (+6.93 Thousand shares)
Q4 2021